Pediatric depression: an evidence-based update on treatment interventions

Amy H Cheung1, Nicole Kozloff, Diane Sacks

  • 1Department of Psychiatry, University of Toronto, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. dramy.cheung@gmail.com

Insights

Pediatric depression significantly impacts youth health and functioning. Primary care providers (PCPs) can improve recognition and management, offering initial support or referring to specialists for moderate-to-severe cases.

Area of Science:

  • Pediatric mental health
  • Primary care practice
  • Child and adolescent psychiatry

Background:

  • Pediatric depression is prevalent and has long-term negative consequences on health and functioning.
  • Primary care providers (PCPs) face barriers in managing childhood depression despite their crucial role.

Purpose of the Study:

  • To provide practical guidance for PCPs on managing pediatric depression.
  • To summarize recent evidence on the identification, assessment, and treatment of depression in young people.

Main Methods:

  • Literature review of recent evidence on pediatric depression management.
  • Focus on practical strategies for PCPs in primary care settings.

Main Results:

  • Mild depression in children/adolescents warrants active support and monitoring.
  • Moderate-to-severe depression may require psychotherapy and/or antidepressants, potentially involving specialist referral.
  • Less evidence exists for treating depression in children under 12, suggesting earlier specialist referral.

Conclusions:

  • PCPs can significantly enhance the recognition and management of pediatric depression.
  • Effective management yields substantial individual and societal benefits.
  • Early intervention and appropriate referral pathways are crucial for optimal outcomes.

Related Concept Videos

Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...